ClinicalTrials.Veeva

Menu

Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.

G

Grigore T. Popa University of Medicine and Pharmacy

Status

Completed

Conditions

CKD Stage 5
Cognitive Impairment
Frailty
CKD Stage 4

Study type

Observational

Funder types

Other

Identifiers

NCT05705011
Nephrogeriatrics

Details and patient eligibility

About

This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease ].

The main question[s] it aims to answer are:

  • What determines the time to initiate dialysis? Cognitive impairment or frailty?
  • What does predict the time to death? Presence of frailty or cognitive impairment?
  • What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?

Enrollment

240 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients age 65 years or older.
  • CKD stage 4 and 5 who were identified by two consecutive measurements of estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 separated by more than 3 months.

Exclusion criteria

  • Patients younger than 65 years old.
  • Chronic kidney disease stages 1,2, and 3.
  • Dialysis dependence
  • History of kidney transplantation.
  • Initial visit with the health care provider.
  • Recent acute kidney injury.
  • Patients who had been hospitalized for more than 2 months before the visit (because long hospitalization might affect the degree of frailty)
  • Patients with myocardial infarction and cerebrovascular accident 3 months before the assessment
  • Patients who are blind or with limb amputation.
  • Patients who refuse to participate.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems